Purpose: The repair and reconstruction of bone defects resulting from tumor-related bone resection surgery face significant challenges. Developing biomaterials with dual functions of tumor therapy and bone regeneration is a promising strategy for osteosarcoma treatment. Methods and Results: In this study, gallium-doped bioactive glass nanoparticles (GaBG NPs) with Ga contents of 5– 15 mol% were synthesize and integrated into thiolated chitosan (CS-NAC) and silk fibroin (SF) composites to fabricate hydrogels systems for post-surgical bone repair applications. The optimized hydrogel system exhibited good injectability with a gelation time of approximately 4 min, moderate mechanical strength (> 3 kPa), high porosity, and sustained release of Si, Ca, and Ga ions within physiologically safe levels. In vitro, studies demonstrated that the GaBG-embedded hydrogels remarkably advanced the proliferation and osteogenic differentiation of MC3T3-E1 cells, while significantly inhibiting the growth of UMR-106 osteosarcoma cells, with the 15GaBG/CNS hydrogel reducing cell viability to < 5% at 72 h. In a rat model of critical-sized calvarial defects, new bone formation reached 55 ± 8% of defect area after 8 weeks without additional cells or growth factors. Moreover, an osteosarcoma model in nude mice confirmed that the 15GaBG/CNS hydrogel significantly suppressed tumor growth without inducing detectable adverse effects in major organs. Conclusion: These findings indicate that the developed GaBG/CNS composite hydrogels possess considerable potential for simultaneous bone regeneration and osteosarcoma inhibition. Keywords: thiolated chitosan, silk fibroin, gallium-doped bioactive glass, Injectable biomaterial, bone tissue engineering, osteosarcoma therapy
Liu et al. (Thu,) studied this question.